 coagulation-fibrinolysi abnorm acut chronic phase cerebr thrombosi embol plasma concentr fibrinogen plasmin-alpha plasmin inhibitor complex dimer antithrombin iii activ patient cerebr thrombosi patient cerebr embol acut day subacut day chronic equal day period control cerebr thrombosi fibrinogen level stage wherea plasmin-alpha plasmin inhibitor complex dimer level subacut chronic period antithrombin iii activ acut stage elev fibrinogen plasmin-alpha plasmin inhibitor complex level acut stage patient infarct size patient infarct size similar chang patient cerebr embol result enhanc coagul exist stage endogen fibrinolysi subacut chronic period larg proport patient cerebr thrombosi embol